Table 1 Brief information and main uses of five public cohorts.
Cohort | Sample size | PMID | Platform | Main use |
|---|---|---|---|---|
TCGA-BRCA | 1015 | NA | NA | Prognostic, immune, metabolic and therapeutic status |
METABRIC | 1764 | 22,522,925 | Illumina HT-12 v3 | Prognostic validation |
ICGC-KR | 50 | NA | Illumina HiSeq 2000 | Prognostic validation |
GSE20685 | 327 | 25,887,482 | GPL570 | Prognostic validation |
GSE42568 | 104 | 23,740,839 | GPL570 | Prognostic validation |
